Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SL807P refers to a genomic pseudogene sequence related to the 7SL RNA, the RNA component of the signal recognition particle (SRP)[1][6]. 7SL RNA itself is a well-characterized non-coding RNA essential for cotranslational targeting of secretory and membrane proteins, but RN7SL807P is a truncated, non-functional copy created by reverse transcription and integration into DNA[6]. Pseudogenes like RN7SL807P do not produce functional RNA or protein and are not known to serve as therapeutic targets, nor do they currently have described roles in disease, drug interaction, or biomarker utility[1][6]. Misspelling or information confusion can arise because functional members of the RN7SL family (such as RN7SL1) are biologically active, but RN7SL807P is only a genomic relic that does not participate in cellular processes[1][4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 807, pseudogene (RN7SL807P).